Tag Archives: Biodefense

Getting Ahead of Ebola and Other Infectious Threats—Overturning Assumptions

ebola

Ebola was one of the biggest stories of 2014 (with Ebola fighters named the TIME Person of the Year), and the epidemic has led to renewed interest from governments and philanthropies to tackle the problem of emerging infectious diseases. To discuss the lessons learned and new approaches being taken in light of the Ebola crisis, BIO hosted a panel today at the 17th Annual BIO CEO & Investor Conference here in New York, moderated by Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Hill: Will Support for Biomedical Research Be Dead on Arrival?

ebola

In an op-ed over at The Hill, Dr. Claire Pomeroy, an infectious disease specialist and president of the Albert and Mary Lasker Foundation, discusses an important question: “How is it that the United States, which has historically held the global lead in medical innovation, was caught flat-footed by Ebola?” Dr. Pomeroy points to a lack of federal funding for medical research as one of the primary culprits for our lack of effective Ebola answers, a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Bavarian Nordic CEO Paul Chaplin in San Jose Mercury News: Why an Ebola Vaccine Still Matters

ebola

The San Jose Mercury News this weekend published an op-ed by Paul Chaplin, the CEO of Bavarian Nordic and a co-chair of the Alliance for Biosecurity which discussed the continuing need to develop an Ebola vaccine – as well as continued federal investments in the programs which fund such research. As Dr. Chaplin notes, all of the Ebola drug and vaccine candidates currently in development have received U.S. federal funding. Why do medical countermeasures against Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

U-T San Diego Commentary: Lack of Preparedness to Ebola Is Symptom of Larger Disease

admin-ajax

Last week, the U-T San Diego published an op-ed by Betrand Liang, CEO of Pfenex Inc., a BIO member, arguing that our current lack of vaccines and therapies for Ebola is a symptom of a larger problem. That problem, Liang argues, is a lack of funding for critical biodefense programs which Congress passed in 2004 as a way to prepare us for biological agents like anthrax, smallpox, and Ebola, as well as chemical, radiological, and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Presents at 2014 Biological Weapons Convention Meeting of Experts

Palais des nations

Last week marked the annual Biological Weapons Convention (BWC) Meeting of Experts in Geneva. The BWC is a multi-national treaty prohibiting the manufacture of biological weapons, and also contains provisions related to national implementation and multi-national coordination for preparedness and assistance. Each year a Meeting of Experts takes place to discuss ongoing issues related to the implementation of the treaty. This year, for the first time ever, BIO was invited to present on novel technologies Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,